BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20170101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181210
DTEND;VALUE=DATE:20181212
DTSTAMP:20260515T005735
CREATED:20180613T100920Z
LAST-MODIFIED:20180613T101345Z
UID:16240-1544400000-1544572799@www.pharmajournalist.com
SUMMARY:Cold Chain Distribution
DESCRIPTION:SMi proudly presents the 13th annual Cold Chain Distribution Conference and Exhibition\, taking place at the Copthorne Tara Hotel in Kensington\, London between the 10th – 11th December. \n\nThe 13th annual event will specifically focus on recent advances in temperature-controlled logistic solutions and the impact of regulatory changes on this multi-billion-dollar industry. The event will also address the impact of the overwhelming digitalisation of the industry and how companies\, from biotech’s to pharma\, need to adapt\, as well as the crucial challenges of supply chain visibility and data integrity in the cold chain industry. \nThe two-day event will also look at various developments within the industry\, guiding companies on how best to ensure costs are kept low\, and quality remains high\, whilst simultaneously staying compliant to global regulations. \nThis year’s event will continue to lead with its unrivalled panel of experts bringing you the most insightful presentations and issues in the field of temperature-controlled distribution. \nChairs for 2018: \n\nBob Hayes\, Director\, SeerPharma (UK)\nTony Wright\, CEO\, Exelsius\n\nFeatured Speakers: \n\nBob Hayes\, Director\, SeerPharma (UK)\nStephen Mitchell\, Quality Lead Logistics Partnerships\, GSK\nGianneOlaes-Dénis\, Supply Chain Quality Manager\, SanofiGenzymeEurope\nStefan Braun\, Managing Director\, SmartCAE\nGianpieroLorusso\, Director\, Supply Operations and GS\, Merck\nFrancicso Rizzuto\, Cargo Specialist\, Manager for Europe\, IATA\nMarco Gaudesi\, Pharmacist – GDP and Cold Chain Referent\, MSF\nHenk Mulder\, Head\, Digital Cargo\, IATA\n\nKey Highlights this December: \n\nEvaluate the current GDP guidelines\, with reference to the recently published PQG/ECA guide and discover the implications for everyday practice\nExplore the overwhelming digitalisation of the supply chain and identify the subsequent security issues involved\nDiscover the temperature-controlled logistic solutions to best optimize your supply chain\nDiscuss the technical agreements within the supply chain and find out what questions you should be asking\nIdentify the challenges for the supply chain within emerging markets and discover the best solutions for optimization of your process\n\nView the full agenda online: www.coldchain-distribution.com/pj \nEARLY-BIRD RATES: \n\nBOOK BY 29TH JUNE AND SAVE £400\nBOOK BY 28TH SEPTEMBER AND SAVE £300\nBOOK BY 31ST OCTOBER AND SAVE £100\n\nTo learn more about SMi’s Cold Chain Distribution\, and to register online\, visit www.coldchain-distribution.com/pj
URL:https://www.pharmajournalist.com/event/cold-chain-distribution/
LOCATION:Copthorne Tara Hotel\, Scarsdale Place\, Kensington\, United Kingdom
ORGANIZER;CN="SMi Events":MAILTO:psolanki@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181210
DTEND;VALUE=DATE:20181213
DTSTAMP:20260515T005735
CREATED:20181016T110516Z
LAST-MODIFIED:20181016T110516Z
UID:18021-1544400000-1544659199@www.pharmajournalist.com
SUMMARY:Antigen-Specific Immune Tolerance Europe Summit
DESCRIPTION:Optimizing the Discovery\, Translation and Clinical Development of Safe and Effective Antigen-Specific Immune Tolerance Inducing Therapies to Treat Autoimmune Diseases. \n \nThe clinical heterogeneity of more than 80 autoimmune diseases presents a significant challenge with respect to the development of therapies designed to re-establish self-tolerance. As the first generation of antigen-specific immune tolerance therapies enters the clinic and excitement around the recent deals\, partnerships\, IPOs and investments reaching new heights\, now is the time for an industry forum for large pharma\, pioneering biotech and academia to unite. \nTackling key R&D challenges\, such as antigen identification\, animal model predictability\, translation and clinical design\, the Antigen-Specific Immune Tolerance Europe Summit is the first European centric\, dedicated platform that brings key decision makers together to successfully translate ground breaking science into a novel class of therapies to treat autoimmunity. \nTo learn more about this event\, and to register online\, visit http://www.as-immunetolerance-eu.com/
URL:https://www.pharmajournalist.com/event/antigen-specific-immune-tolerance-europe-summit/
LOCATION:Park Plaza Victoria\, 239 Vauxhall Bridge Road\, London\, SW1V 1EQ\, United Kingdom
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR